You have 9 free searches left this month | for more free features.

Taxotere

Showing 1 - 25 of 895

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023

Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

Recruiting
  • Gastric Adenocarcinoma
  • Adenocarcinoma of Gastroesophageal Junction
  • Docetaxel for injection (Albumin-bound)
  • Taxotere
  • Guangzhou, China
    Ethics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023

Advanced Solid Tumors Trial in Cangzhou (Docetaxel for Injection (Albumin-bound), Taxotere)

Active, not recruiting
  • Advanced Solid Tumors
  • Docetaxel for Injection (Albumin-bound)
  • Taxotere
  • Cangzhou, China
    Cangzhou Central Hospital
Jan 27, 2022

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • Norfolk, Nebraska
  • +2 more
Aug 10, 2022

Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

Active, not recruiting
  • Metastatic Prostatic Adenocarcinoma
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 30, 2023

Breast Cancer Trial in Oslo (Docetaxel)

Completed
  • Breast Cancer
  • Oslo, Norway
    RRHF
Apr 21, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Peritoneal Carcinomatosis Trial in Baltimore (Intraperitoneal docetaxel)

Recruiting
  • Peritoneal Carcinomatosis
  • Intraperitoneal docetaxel
  • Baltimore, Maryland
    Johns Hopkins University
Nov 7, 2022

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)

Completed
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 29, 2021

Head Neck Cancer Trial in Washington (Cisplatinum, Docetaxel, Carboplatin)

Active, not recruiting
  • Head and Neck Cancer
  • Washington, District of Columbia
    George Washington University-Medical Faculty Associates
Nov 14, 2022

Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)

Recruiting
  • Soft Tissue Sarcoma
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

NSCLC Trial (Pembrolizumab, Docetaxel)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 18, 2022

HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)

Recruiting
  • HER-2 Positive Breast Cancer
  • TCbHP VS ddEC-THP
  • Tianjin, Tianjin, China
    Breast Oncology, Tianjin Medical University Cancer Institute and
May 15, 2023

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

Not yet recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +4 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Jun 26, 2023

Testicular Cancer Trial in Houston, Seattle (Gemcitabine, Docetaxel, Melphalan)

Active, not recruiting
  • Testicular Cancer
  • Houston, Texas
  • +1 more
Dec 5, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022